Brief reports
Recent trends in hospital management practices and prognosis after acute myocardial infarction in patients with kidney disease

https://doi.org/10.1016/j.amjcard.2004.07.116Get rights and content

Patients who have kidney disease receive aspirin, β blockers, lipid-lowering therapy, thrombolytic agents, and coronary interventions less often than patients who have normal kidney function. The odds of dying during hospitalization for acute myocardial infarction were significantly higher among patients who had kidney disease than among those who did not have kidney disease after adjusting for several demographic and clinical confounders and year of hospitalization.

Section snippets

Acknowledgment

This study was made possible through the cooperation of the administration, medical records, and cardiology departments of participating greater Worcester hospitals.

References (19)

There are more references available in the full text version of this article.

Cited by (0)

This study was supported by grant RO1 HL35434 from the National Heart, Lung, and Blood Institute, Bethesda, Maryland, and grant K23 DK02904 from the National Institutes of Diabetes, Digestive, and Kidney Diseases, Bethesda, Maryland.

View full text
Copyright © 2004 Excerpta Medica Inc. All rights reserved.